Topics To Cover
The PBCV – Clinical Trials Conference, taking place on April 23–24, 2026, at Shanghai, China, will explore a comprehensive range of topics aimed at deepening understanding of the latest research, innovations, regulations, and challenges in the field of clinical trials, pharmaceutical development, patient engagement, and health systems. The following are some of the major focus areas, though the conference welcomes a broad spectrum of contributions:
Clinical Trial Methodology, Design, and Innovation
-
Clinical Trial Methodology, Design, and Innovation
- Adaptive, platform, and decentralized trial designs
- Real-world evidence (RWE) and pragmatic clinical trials
- Biomarker-driven and personalized trial frameworks
- Translational science from bench to bedside
-
Drug Development, Chronic Disease, and Therapeutic Advances
- Clinical trials in chronic diseases: cardiovascular, diabetes, oncology
- New drug application (NDA) strategies and regulatory submissions
- Clinical trial phases: I to IV, with focus on efficacy and safety
- Combination therapy and innovative treatment approaches
-
Regulatory Affairs and Global Harmonization
- Updates from FDA, EMA, and ICH regulatory guidelines
- Clinical trial applications (CTAs) and investigational new drugs (INDs)
- Ethics committee and institutional review board (IRB) best practices
- Regulatory strategies for multi-country trials
-
Clinical Research Education and Workforce Development
- Investigator and coordinator training programs
- Good Clinical Practice (GCP) compliance and site audits
- E-learning platforms and certifications in clinical research
- Building global research capacity through education and mentorship
-
Early Phase and Critical Care Trials
- Trial design for high-risk and ICU patient populations
- First-in-human and dose-escalation studies
- Emergency-use trials and rapid deployment protocols
- Safety signal detection and response strategies
-
Mental Health, Neuroscience, and Psychiatric Trials
- Clinical trials in anxiety, depression, and neurodegenerative disorders
- Inclusion of mental health assessments in broader trials
- Ethics and data integrity in psychiatric research
- Placebo response and endpoint optimization
-
Public Health, Preventive Trials, and Community Engagement
- Vaccine development and immunogenicity studies
- Screening and preventive intervention trials
- Community-based participatory research models
- Health equity and inclusion in participant recruitment
Chronic Disease and Long-Term Follow-Up Studies
-
Chronic Disease and Long-Term Follow-Up Studies
- Longitudinal safety and efficacy assessments
- Outcomes research in chronic conditions
- Registries, real-world data, and post-marketing surveillance
- Multi-disciplinary approaches to complex trials
-
Digital Health, Data, and Artificial Intelligence
- eConsent, ePROs, and digital data capture systems
- AI/ML tools for patient selection, endpoint prediction, and monitoring
- Integration of EHRs and wearable devices in trial protocols
- Risk-based monitoring and decentralized oversight
-
Workforce Retention and Clinical Site Development
- Workforce development and staff retention in clinical research
- Site sustainability and performance metrics
- Flexible staffing, remote coordination, and hybrid models
- Site certification, accreditation, and quality improvement
-
Pediatric and Adolescent Clinical Research
- Ethical considerations and age-appropriate protocols
- Chronic and rare disease trials in pediatric populations
- Engagement strategies for adolescents and families
- Drug safety, dosing, and efficacy across developmental stages
-
Ethics, Diversity, and Sustainability in Clinical Trials
- Informed consent and participant autonomy
- Enhancing diversity in trial enrollment and leadership
- Environmentally responsible trial operations
- Addressing systemic barriers to global participation
-
Geriatric, Palliative, and End-of-Life Research
- Inclusion of older adults in clinical trials
- Palliative care trials: symptom relief, QOL, and caregiver outcomes
- Advance directives and ethical endpoints in terminal trials
- Polypharmacy and safety in older populations
-
Infectious Disease Trials and Pandemic Readiness
- Trial design in outbreak and pandemic conditions
- Vaccine efficacy, safety, and immunogenicity studies
- Antiviral and antimicrobial stewardship trials
- Post-COVID-19 insights and preparedness planning
Why These Topics Matter in Today’s Clinical Research Landscape
- Accelerating Innovation: Advancing clinical trial science is essential to delivering faster, safer, and more effective treatments.
- Enhancing Safety and Trust: Rigorous protocols and data transparency strengthen public confidence and regulatory approval.
- Harnessing Technology: Digital transformation is redefining trial conduct, data quality, and accessibility.
- Improving Inclusivity: Ethical and culturally competent trial design ensures research reaches all populations.
- Fostering Global Partnerships: International collaboration drives equitable research development and global health solutions.
- Responding to Global Health Needs: The conference provides a vital platform to tackle current and future health crises through clinical research.
These focus areas reflect the evolving nature of clinical research and healthcare, emphasizing the need for innovation, transparency, global collaboration, and sustainable practices. The PBCV – Clinical Trials Conference is an essential gathering for professionals aiming to shape the future of evidence-based medicine and therapeutic advancement.
